These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6474414)

  • 61. Influence of glutathione and its derivatives on fibrin polymerization.
    Geer CB; Stasko NA; Rus IA; Lord ST; Schoenfisch MH
    Biomacromolecules; 2008 Jul; 9(7):1876-82. PubMed ID: 18570468
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Determination of soluble fibrin by turbidimetry of its protamine sulphate-induced paracoagulation.
    Wieding JU; Eisinger G; Köstering H
    J Clin Chem Clin Biochem; 1989 Feb; 27(2):57-63. PubMed ID: 2746164
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Formation of fibrin gel in fibrinogen-thrombin system: static and dynamic light scattering study.
    Kita R; Takahashi A; Kaibara M; Kubota K
    Biomacromolecules; 2002; 3(5):1013-20. PubMed ID: 12217048
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Unstimulated and thrombin-stimulated platelets binding to immobilized fibrinogen and fibrin on polystyrene supports.
    Martínez-Sales V; Vila V; Réganon E; Aznar J
    Haemostasis; 1995; 25(4):158-65. PubMed ID: 7557654
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clotting of bovine fibrinogen. Calcium binding to fibrin during clotting and its dependence on release of fibrinopeptide B.
    Mihalyi E
    Biochemistry; 1988 Feb; 27(3):967-76. PubMed ID: 3365373
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy.
    Hogg PJ; Jackson CM
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3619-23. PubMed ID: 2726739
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fibrin assembly in human plasma and fibrinogen/albumin mixtures.
    Torbet J
    Biochemistry; 1986 Sep; 25(18):5309-14. PubMed ID: 3768349
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Characterization of the kinetic pathway for fibrin promotion of alpha-thrombin-catalyzed activation of plasma factor XIII.
    Naski MC; Lorand L; Shafer JA
    Biochemistry; 1991 Jan; 30(4):934-41. PubMed ID: 1989686
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Complexation with heparin prevents adhesion between fibrin-coated surfaces.
    Retzinger GS; Chandler LJ; Cook BC
    J Biol Chem; 1992 Dec; 267(34):24356-62. PubMed ID: 1447186
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Effect of phosphatidyl serine on conversion of fibrinogen to fibrin].
    Byshevskiĭ ASh; Leven PI; Sokolovskiĭ SR
    Vopr Med Khim; 1983; 29(4):16-22. PubMed ID: 6623990
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Changes in adsorbed fibrinogen upon conversion to fibrin.
    Evans-Nguyen KM; Fuierer RR; Fitchett BD; Tolles LR; Conboy JC; Schoenfisch MH
    Langmuir; 2006 May; 22(11):5115-21. PubMed ID: 16700602
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inhibition of fibrin polymerization by fragment d is affected by calcium, Gly-Pro-Arg and Gly-His-Arg.
    Furlan M; Rupp C; Beck EA
    Biochim Biophys Acta; 1983 Jan; 742(1):25-32. PubMed ID: 6824684
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Catalytic competence of human alpha- and gamma-thrombin in the activation of fibrinogen and factor XIII.
    Lewis SD; Lorand L; Fenton JW; Shafer JA
    Biochemistry; 1987 Dec; 26(24):7597-603. PubMed ID: 3427095
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The role of fibrinogen alpha C-domains in the fibrin assembly process.
    Medved' LV; Gorkun OV; Manyakov VF; Belitser VA
    FEBS Lett; 1985 Feb; 181(1):109-12. PubMed ID: 3972099
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of temperature on dynamic viscoelasticity during the clotting reaction of fibrin.
    Kaibara M; Fukada E
    Biochim Biophys Acta; 1977 Oct; 499(3):352-61. PubMed ID: 562194
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Formation of soluble fibrin oligomers in purified systems and in plasma.
    Alkjaersig N; Fletcher AP
    Biochem J; 1983 Jul; 213(1):75-83. PubMed ID: 6615433
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The circulatory half-lives of alpha-profibrin and alpha-fibrin monomer, and comparisons with other fibrin(ogen) derivatives.
    Shainoff JR; DiBello PM
    Thromb Haemost; 2003 Jan; 89(1):48-52. PubMed ID: 12540953
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Properties of 2 fibrin monomer species which differ in the degree of thrombin activation. Characteristics of successively appearing active sites].
    Lugovskoĭ EV; Gogolinskaia GK; Derzskaia SG; Belitser VA
    Biokhimiia; 1978 Jun; 43(6):1045-53. PubMed ID: 667211
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Conversion of fibrinogen to fibrin induced by preferential release of fibrinopeptide B.
    Dyr JE; Blombäck B; Hessel B; Kornalík F
    Biochim Biophys Acta; 1989 Jan; 990(1):18-24. PubMed ID: 2914147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.